Vanda Pharmaceuticals (VM4.F) Q1 2026 Earnings

11FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-2.01
-1.45
-0.88
-0.31

Details

Expected EPS
-0.821028
Actual EPS
-2.0125712
Surprise EPS
-1.19
Surprise Percent
+145.13%

Description

Vanda Pharmaceuticals (VM4.F) has reported earnings of -2.0125712 per share for Q1 2026.

0 Comments

Share your thoughts